Beydon, Maxime
McCoy, Sara
Nguyen, Yann http://orcid.org/0000-0002-0866-3824
Sumida, Takayuki
Mariette, Xavier
Seror, Raphaèle http://orcid.org/0000-0002-5523-1856
Article History
Accepted: 7 November 2023
First Online: 18 December 2023
Competing interests
: S.M. has received consulting fees from Bristol Myers Squibb, Horizon, iCell, Kiniksa, Novartis, Otsuka, Target RWE and Visterra. X.M. has received consulting fees from Astra Zeneca, Bristol Myers Squibb, Galapagos, GSK, Novartis and Pfizer. R.S. has received consulting fees from Amgen, Bristol Myers Squibb, Boehringer, GSK, Janssen and Pfizer, and travel fees from Amgen and GSK. The remaining authors declare no competing interests.